NITYR® (nitisinone) Tablets are approved in the USA, Australia and the Kingdom of Saudi Arabia in 2, 5 and 10 mg strengths and in the EU and Chile in 10 mg strength. Cycle Pharmaceuticals’ nitisinone products are also approved under a different name, NITISINONE TABLETS, in Canada in 2, 5, and 10 mg strengths. Registration conditions differ internationally.
NITYR® is a registered trademark of Cycle Pharmaceuticals Limited in the United States.
To report an Adverse Event please click here.